한글목차

세계의 암 생검 시장은 2025년에 336억 9,000만 달러로 추정되고, 2032년 879억 9,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 14.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

생검이란, 체내의 조직편이나 세포의 샘플을 채취해, 실험실로 검사하기 위한 의료 검사입니다. 한편, 암 생검에서는 암의 존재, 원인, 범위를 발견하기 위해, 이환 환자의 조직 또는 세포를 채취합니다. 이렇게, 세계에서 암의 부담이 증가하고 있기 때문에 암 생검 사용도 급속도로 증가하고 있습니다.

시장 역학

종양성 질환의 유병률 증가, 노인 증가, 액체 생검의 등장과 채용 증가, 유전자 검사 및 유전성 종양성 질환에 관한 사람들의 의식 증가, 생검 기술의 지속적인 개발은 세계 암 생검 시장의 성장을 증가시킬 것으로 예상되는 주요 요인입니다.

예를 들어, 2022년 5월, 조기 암 발견을 위한 고성능, 저가격의 새로운 클래스의 리퀴드 바이옵시 검사 개발 기업인 Delfi Diagnostics는 차세대 리퀴드 바이옵시 플랫폼의 여러 응용 예를 발표했습니다.

본 조사의 주요 특징

• 본 보고서는 세계의 암 생검 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모와 복합연간 성장률(CAGR%)을 기재하고 있습니다.
• 또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역에 의한 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 다음 파라미터를 바탕으로 세계 암 생검 시장의 주요 기업 프로파일을 제공합니다.
• 본 보고서로부터 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등이 산업의 다양한 이해 관계자를 대상으로 합니다.
• 이해관계자는 세계의 암 생검 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map (COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 종양질환의 부담 증대
  • 기술적 및 임상적 과제
  • 액체 생검 채용 증가
• 영향 분석
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• Porter's Five Forces 분석
• 합병과 인수 시나리오

제4장 암 생검 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 암 생검 시장 : 제품별, 2020-2032년

• 소개
• 기기
• 키트와 소모품
• 서비스

제6장 세계의 암 생검 시장 : 생검 유형별, 2020-2032년

• 소개
• 조직 생검
• 바늘 생검
• 액체 생검
• 기타

제7장 세계의 암 생검 시장 : 용도별, 2020-2032년

• 소개
• 유방암
• 대장암
• 자궁경부암
• 폐암
• 전립선암
• 피부암
• 혈액암
• 신장암
• 간암
• 췌장암
• 난소암
• 기타

제8장 세계의 암 생검 시장 : 지역별, 2020-2032년

• 소개
• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동

제9장 경쟁 구도

• QIAGEN
• Illumina, Inc.
• Angle PLC
• Myriad Genetics
• COUNSYL, Inc.
• Hologic, Inc.
• Biocept, Inc.
• Thermo Fisher Scientific, Inc.
• Danaher
• F. Hoffmann-La Roche Ltd.
• Epigenomics AG
• BD(Becton, Dickinson and Company)
• Helio Health(Laboratory for Advanced Medicine)

제10장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Cancer Biopsy Market is estimated to be valued at USD 33.69 Bn in 2025 and is expected to reach USD 87.99 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2032.

A biopsy is a medical test to remove the piece of tissue or a sample of cells from the body so that it can be tested in a laboratory. While, in cancer biopsy, a tissue or cells of the affected patient is taken to discover the presence, cause, or extent of cancer. Thus, with the rising burden of cancer across the globe, the use of cancer biopsy or cancer biopsies also increasing with a rapid pace.

Market Dynamics:

Increasing prevalence of oncology disorders, growing geriatric population, advent of liquid biopsy or increasing adoption of liquid biopsies, increasing awareness among people about genetic testing and inherited oncology diseases, and ongoing developments in biopsy techniques are major factors expected to augment the growth of the global cancer biopsy market.

For instance, in May 2022, Delfi Diagnostics, a developer of a new class of high-performance and affordable liquid biopsy tests for early cancer detection, presented multiple applications for its next-generation liquid biopsy platform. Delfi presented a trial-in-progress update on DELFI-L101, a prospective, case-control study to train and test classifiers for lung cancer detection.

Key features of the study:

• This report provides in-depth analysis of the global cancer biopsy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cancer biopsy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include QIAGEN, Illumina, Inc., Angle PLC, Myriad Genetics, COUNSYL, Inc., Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, F. Hoffmann-La Roche Ltd., Epigenomics AG, BD (Becton, Dickinson and Company), and Helio Health (Laboratory for Advanced Medicine), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global cancer biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biopsy market.

Detailed Segmentation:

• Global Cancer Biopsy Market , By Product:
  • Instruments
  • Kits and Consumables
  • Services
• Global Cancer Biopsy Market , By Biopsy Type:
  • Tissue Biopsy
  • Needle Biopsy
  • Fine Needle Aspiration (FNA)
  • Core Needle Biopsy (CNB)
  • Liquid Biopsy
  • Others
• Global Cancer Biopsy Market, By Application:
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Prostate Cancer
  • Skin Cancer
  • Blood Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others
• Global Cancer Biopsy Market , By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • QIAGEN
  • Illumina, Inc.
  • Angle PLC
  • Myriad Genetics
  • COUNSYL, Inc.
  • Hologic, Inc.
  • Biocept, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • Hoffmann-La Roche Ltd.
  • Epigenomics AG
  • BD (Becton, Dickinson and Company)
  • Helio Health (Laboratory for Advanced Medicine)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Biopsy Type
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising burden of oncology disorders
  • Technical and clinical challenges
  • Increasing adoption of liquid biopsies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Cancer Biopsy Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Cancer Biopsy Market, By Product, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Kits and Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Cancer Biopsy Market, By Biopsy Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Tissue Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Needle Biopsy
  • Fine Needle Aspiration (FNA)
  • Core Needle Biopsy (CNB)
• Liquid Biopsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Cancer Biopsy Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Breast Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Colorectal Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cervical Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Lung Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Prostate Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Skin Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Blood Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Kidney Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Liver Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Pancreatic Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Ovarian Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Cancer Biopsy Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)

9. Competitive Landscape

• QIAGEN
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Illumina, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Angle PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Myriad Genetics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• COUNSYL, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biocept, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Epigenomics AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BD (Becton, Dickinson and Company)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Helio Health (Laboratory for Advanced Medicine)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us